Form 4 · Filed Jun 3, 2026, 10:37 PM UTC
TNGX/Tango Therapeutics, Inc.
Crystal Adam — President, R&D
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | M | other | 27,000 | $5 | $140,400 | 142,743 |
| Jun 1, 2026 | S | sell | 6,140 | $22 | $136,627 | 136,603 |
| Jun 1, 2026 | S | sell | 20,860 | $23 | $480,944 | 115,743 |
| Jun 1, 2026 | M | other | 27,000 | — | — | 341,040 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-255940